Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Ciclesonide MDI Once Daily vs Twice Daily in Mild to Moderate Asthma
NCT00174733Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2005
- Primary completion
- Feb 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (3 arms), sponsored by Sanofi. Primary endpoint: Change from baseline to Week 12 in FEV1. Started Jul 2005; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00174733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174733.